Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction.

  • Authors : Bhatt AS; Kaiser Permanente San Francisco Medical Center and Division of Research, San Francisco, CA, USA.; Division of Cardiovascular Medicine, Stanford University School of Medicine, Palo Alto, CA, USA.

Subjects: Valsartan*/Valsartan*/Valsartan*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/physiopathology

  • Source: European journal of heart failure [Eur J Heart Fail] 2024 May; Vol. 26 (5), pp. 1172-1174. Date of Electronic Publication: 2024 Apr 07.Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844

تفاصيل العنوان

×
Academic Journal

Effects of angiotensin receptor-neprilysin inhibitor on ketone body metabolism in pre-heart failure/heart failure patients.

  • Authors : Kashiwagi Y; Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-shimbashi, Minato-ku, Tokyo, 105-8461, Japan. .; Nagoshi T

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/metabolism ; Ketone Bodies*/Ketone Bodies*/Ketone Bodies*/blood

  • Source: Scientific reports [Sci Rep] 2024 Jul 17; Vol. 14 (1), pp. 16493. Date of Electronic Publication: 2024 Jul 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

The impact of discontinuation of sacubitril-valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction.

  • Authors : Amin OA; Department of Cardiology, Faculty of Medicine, Beni-Suef University; Beni-Suef-Egypt.

Subjects: Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/Angiotensin-Converting Enzyme Inhibitors*/therapeutic use ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy; Aminobutyrates

  • Source: Anatolian journal of cardiology [Anatol J Cardiol] 2021 Mar; Vol. 25 (3), pp. 163-169.Publisher: KARE publishing Country of Publication: Turkey NLM ID: 101652981 Publication Model: Print Cited Medium: Internet ISSN: 2149-2271

تفاصيل العنوان

×
Academic Journal

The effects of valsartan on scar maturation in an experimental rabbit ear wound model.

  • Authors : Kurt M; Department of Plastic Surgery, Tekirdag State Hospital, Tekirdag, Turkey.; Akoz Saydam F

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*pharmacology ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*pharmacology ; Cicatrix, Hypertrophic/Cicatrix, Hypertrophic/Cicatrix, Hypertrophic/*prevention & control

  • Source: Journal of plastic surgery and hand surgery [J Plast Surg Hand Surg] 2020 Dec; Vol. 54 (6), pp. 382-387. Date of Electronic Publication: 2020 Sep 11.Publisher: Medical Journals Sweden AB Country of Publication: Sweden NLM ID: 101534130 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Safety and Tolerability of Initiating Maximum-Dose Sacubitril-Valsartan in Patients on Target Dose Renin-Angiotensin System Inhibitors.

  • Authors : Norberg H; Department of Public Health and Clinical Medicine, Umeå University, 901 87 Umeå, Sweden.; Department of Pharmacology and Clinical Neuroscience, Umeå University, 901 87 Umeå, Sweden.

Subjects: Drug Substitution*; Aminobutyrates/Aminobutyrates/Aminobutyrates/*administration & dosage ; Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/Angiotensin Receptor Antagonists/*administration & dosage

  • Source: Cardiovascular therapeutics [Cardiovasc Ther] 2019 Aug 01; Vol. 2019, pp. 6745074. Date of Electronic Publication: 2019 Aug 01 (Print Publication: 2019).Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: eCollection Cited Medium: Internet ISSN: 1755-5922

تفاصيل العنوان

×
  • 1-10 ل  422 نتائج ل ""Valsartan""